|Values are valid only on day of printing.|
Identifying individuals who are at increased risk of adverse drug reactions with irinotecan and who should be considered for decreased dosing of the drug.
Genotyping patients who prefer not to have venipuncture done
See UGT1A1 Test-Performing Algorithm in Special Instructions.
Polymerase Chain Reaction (PCR) with Fragment Analysis by Capillary Gel Electrophoresis
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)